METHODS : Genomic alterations were analyzed using single-nucleotide polymorphism arrays in 46 HER2 immunohistochemistry ( IHC ) 3 + or 2 + / fluorescent in situ hybridization ( FISH ) + breast cancers that were treated with neoadjuvant chemotherapy with paclitaxel , cyclophosphamid , epirubicin , fluorouracil , and trastuzumab .